Click here to participate!
Background:
Contraception policy and practice in BC changed substantially in 2023, including the launch of Canada’s first universal contraception subsidy (April 1 2023) and pharmacist scope expansion granting prescribing authority for contraception (June 1 2023). Together, these changes may expand access to contraception for BC residents, though impacts on access and on patient and provider experiences are not yet known. This study explores pharmacists’ experiences, perceptions, challenges, and opportunities related to contraception prescribing after these policy changes. Your contribution is essential for this research, which may benefit the pharmacy profession, broader healthcare community, and patients.
This study, led by a research team from the UBC Faculty of Pharmaceutical Sciences and the Contraception and Abortion Research Team, aims to understand pharmacist perspectives and experiences related to contraception prescribing and the factors that facilitate and limit this service.
Objectives:
The objectives of this study are to 1) understand BC pharmacists’ activities, perspectives, and intentions related to contraception prescribing and 2) identify barriers to contraception provision and potential mitigation strategies.
Eligibility:
Pharmacists will be eligible to participate in this study if they:
1) Work as a pharmacist in a community pharmacy, primary care setting, or hospital setting within British Columbia
2) Are listed as a registered pharmacist by the College of Pharmacists of British Columbia
Your Voice Matters:
Your responses are critical for health policy and system leaders in BC to understand the experiences of pharmacists following pharmacist expanded scope granting prescriptive authority for minor ailments and contraception. By offering 20 minutes of your time, you will play a significant role in shaping the future of pharmacist practice and contraception service provision in BC. As a token of our appreciation, you will receive $20 by electronic transfer.
To Participate:
Click this link or use the QR code below: https://redcap.link/actpharm3
Survey Details:
Estimated Time: 20 minutes
Compensation: $20 e-transfer
The survey will close on August 30, 2024 at 11:59 pm.
Your participation is entirely voluntary. Your responses will be kept strictly confidential.
Contact:
The study’s Principal Investigator is Dr. Laura Schummers, an Assistant Professor in the Faculty of Pharmaceutical Sciences at UBC. If you have any questions or encounter issues with the survey, please reach out to our research team at pharmcontraception.survey@ubc.ca.